Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Antiarrhythmic drug could also treat PAH, COPD

An FDA-approved antiarrhythmic drug known as dofetilide could be repurposed to treat pulmonary arterial hypertension, researchers have found.

Thumbnail

Successful TMVR hinges on operator experience

The odds of a successful and effective TMVR for the treatment of mitral regurgitation increase alongside an operator’s level of experience, a study published in the Journal of the American College of Cardiology has found.

Thumbnail

Geriatric patients may need special attention in the cardiac ICU

Frailty and cognitive decline may cause geriatric patients to fare worse in a traditional cardiac ICU than expected, according to a Dec. 9 scientific statement from the American Heart Association.

Thumbnail

Obesity mutes efficacy of sodium channel blockers for those with AFib

Atrial fibrillation patients who are obese are less likely to respond to sodium channel blockers than their normal-weight peers, according to a new study.

Thumbnail

Marijuana vapes can generate toxins when heated

Natural compounds mixed into THC vaping liquids could generate toxic chemicals when heated and inhaled, according to research out of Portland State University in Oregon.

Thumbnail

ASTRO releases new radiation therapy guidelines to treat skin cancers

More than 5 million people are diagnosed with skin cancer in the U.S. each year, and an overwhelming majority are categorized as either basal or cutaneous squamous cell carcinoma.

Thumbnail

Cases of chronic HF expected to reach 32M by 2028

Diagnosed cases of chronic heart failure are expected to number 32 million by 2028, according to a report from analytics company GlobalData.

Preventive aspirin obsolete in light of improved access to statins, screenings

Updated screening technologies and more widespread use of statins have rendered aspirin ineffective for the primary prevention of CVD, according to a study published in Family Practice.